The expression of TET1 is greater in tumors that harbor isocitrate dehydrogenase (IDH) mutations (Supplemental Fig. 1C) in both GBM and low-grade gliomas (Supplemental Fig. 1D). The gene discussed is TET1; the disease is glioblastoma.